Trademark Overview
On Thursday, May 15, 2025, a trademark application was filed for THERAVECTYS with the United States Patent and Trademark Office. The USPTO has given the THERAVECTYS trademark a serial number of 79427841. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 17, 2025. This trademark is owned by THERAVECTYS. The THERAVECTYS trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Pharmaceutical product manufacturing services to order for third parties; vaccine manufacturing services to order for third parties.
Pharmaceutical and veterinary products; vaccines; lentiviral vectors for medical, pharmaceutical and veterinary use; chemical, biological and pharmaceutical products and preparations for therapeutic, medical, pharmaceutical and veterinary use; diagnostic preparations for therapeutic, medical and veterinary use; chemical reagents for medical or veterinary use.
Chemical products for use in industry and science; chemical preparations for scientific use, other than for medical or veterinary use; biological preparations for use in industry and science; chemical reagents other than for medical or veterinary use; chemical products for analyses in laboratories other than for medical or veterinary use; diagnostic preparations other than for medical or veterinary use; biological preparations other than for medical or veterinary use; lentiviral vectors for scientific use.
Medical analysis and medical diagnosis services; medical analyses of blood samples; assistance services relating to medicine and health care; provision of medical information.
Scientific research for medical purposes; research and development services for pharmaceutical preparations; conducting clinical trials; clinical research; conducting scientific studies and analyses; biological, biotechnological, biochemical, medical and pharmaceutical research and development services for third parties; evaluation of the efficacy of pharmaceutical products.